MD668Z - Metodă de hemostază conservativă a hemoragiilor gastroduodenale - Google Patents
Metodă de hemostază conservativă a hemoragiilor gastroduodenaleInfo
- Publication number
- MD668Z MD668Z MDS20130031A MDS20130031A MD668Z MD 668 Z MD668 Z MD 668Z MD S20130031 A MDS20130031 A MD S20130031A MD S20130031 A MDS20130031 A MD S20130031A MD 668 Z MD668 Z MD 668Z
- Authority
- MD
- Moldova
- Prior art keywords
- hemostasis
- conservative
- water
- gastroduodenal
- hemorrhages
- Prior art date
Links
- 230000023597 hemostasis Effects 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims abstract description 12
- 206010053768 Gastroduodenal haemorrhage Diseases 0.000 title claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims abstract description 9
- 108090000190 Thrombin Proteins 0.000 claims abstract description 7
- 239000000725 suspension Substances 0.000 claims abstract description 7
- 229960004072 thrombin Drugs 0.000 claims abstract description 7
- 239000000523 sample Substances 0.000 claims abstract description 4
- 210000002784 stomach Anatomy 0.000 claims description 8
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 230000007170 pathology Effects 0.000 abstract description 4
- 238000011477 surgical intervention Methods 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 238000001356 surgical procedure Methods 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 4
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 2
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- 206010049771 Shock haemorrhagic Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 238000011846 endoscopic investigation Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-UHFFFAOYSA-N 2-aminohexanoic acid Chemical compound CCCCC(N)C(O)=O LRQKBLKVPFOOQJ-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- HBGOLJKPSFNJSD-UHFFFAOYSA-N Etamsylate Chemical compound CC[NH2+]CC.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 HBGOLJKPSFNJSD-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229960004817 etamsylate Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 229940010250 vitamin k 2 Drugs 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20130031A MD668Z (ro) | 2013-02-22 | 2013-02-22 | Metodă de hemostază conservativă a hemoragiilor gastroduodenale |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20130031A MD668Z (ro) | 2013-02-22 | 2013-02-22 | Metodă de hemostază conservativă a hemoragiilor gastroduodenale |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD668Y MD668Y (en) | 2013-08-31 |
| MD668Z true MD668Z (ro) | 2014-03-31 |
Family
ID=49117540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20130031A MD668Z (ro) | 2013-02-22 | 2013-02-22 | Metodă de hemostază conservativă a hemoragiilor gastroduodenale |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD668Z (mo) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD835G2 (ro) * | 1996-05-15 | 1998-07-31 | Cicala Evstafii | Metodă de tratament al ulcerului gastroduodenal sângerând |
| MD1249G2 (ro) * | 1998-09-30 | 1999-12-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Metodă de hemostază conservativă a hemoragiilor gastrointestinale |
| MD2323G2 (ro) * | 2003-06-23 | 2004-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Utilizarea bromurii de S-etilizotiouroniu (izoturon) în calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin |
| MD2328G2 (ro) * | 2003-07-14 | 2004-07-31 | Константин ЦЫБЫРНЭ | Adeziv fibrinic şi utilizarea lui pentru hemostază endoscopică a hemoragiilor variceale în ciroza hepatică |
| MD84Z (ro) * | 2009-05-13 | 2010-04-30 | Олег ЗЭНОАГЭ | Metodă de hemostază după extracţia dentară |
| MD344Z (ro) * | 2010-11-30 | 2011-11-30 | Георге АНГЕЛИЧ | Metodă de tratament al rectohemoragiilor variceale la bolnavii cu ciroză hepatică |
| MD372Z (ro) * | 2010-11-30 | 2011-12-31 | Георге АНГЕЛИЧ | Metodă de hemostază endoscopică a ulcerului hemoragic în ciroza hepatică decompensată |
| UA68469U (ru) * | 2011-09-13 | 2012-03-26 | Харьковская Медицинская Академия Последипломного Образования | Способ консервативного гемостаза и остановки кровотечения из верхних и нижних отделов желудочно-кишечного тракта |
-
2013
- 2013-02-22 MD MDS20130031A patent/MD668Z/ro not_active IP Right Cessation
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD835G2 (ro) * | 1996-05-15 | 1998-07-31 | Cicala Evstafii | Metodă de tratament al ulcerului gastroduodenal sângerând |
| MD1249G2 (ro) * | 1998-09-30 | 1999-12-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Metodă de hemostază conservativă a hemoragiilor gastrointestinale |
| MD2323G2 (ro) * | 2003-06-23 | 2004-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Utilizarea bromurii de S-etilizotiouroniu (izoturon) în calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine în cazul miomului uterin |
| MD2328G2 (ro) * | 2003-07-14 | 2004-07-31 | Константин ЦЫБЫРНЭ | Adeziv fibrinic şi utilizarea lui pentru hemostază endoscopică a hemoragiilor variceale în ciroza hepatică |
| MD84Z (ro) * | 2009-05-13 | 2010-04-30 | Олег ЗЭНОАГЭ | Metodă de hemostază după extracţia dentară |
| MD344Z (ro) * | 2010-11-30 | 2011-11-30 | Георге АНГЕЛИЧ | Metodă de tratament al rectohemoragiilor variceale la bolnavii cu ciroză hepatică |
| MD372Z (ro) * | 2010-11-30 | 2011-12-31 | Георге АНГЕЛИЧ | Metodă de hemostază endoscopică a ulcerului hemoragic în ciroza hepatică decompensată |
| UA68469U (ru) * | 2011-09-13 | 2012-03-26 | Харьковская Медицинская Академия Последипломного Образования | Способ консервативного гемостаза и остановки кровотечения из верхних и нижних отделов желудочно-кишечного тракта |
Non-Patent Citations (1)
| Title |
|---|
| Шестопалов С. Н. Клиника, диагностика и лечение желудочно-кишечного кровотечений у обожженных. Челябинск, 1994, с. 26 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD668Y (en) | 2013-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Walker et al. | Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double‐blind study | |
| Mallory et al. | Selective intra-arterial vasopressin infusion for upper gastrointestinal tract hemorrhage: a controlled trial | |
| Hurvitz et al. | Cyclophosphamide therapy in life-threatening vascular tumors | |
| Seear et al. | The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children | |
| Greene et al. | Pulmonary vascular obstruction in severe ARDS: angiographic alterations after iv fibrinolytic therapy | |
| Duan et al. | The effect of pantoprazole and somatostatin combined with thrombin in the treatment of non-esophagogastric varicosity upper gastrointestinal bleeding | |
| MD668Z (ro) | Metodă de hemostază conservativă a hemoragiilor gastroduodenale | |
| Som et al. | New approach to the treatment of esophageal varices | |
| Rudowski | Moynihan Lecture, 1980. Major surgery in haemophilia | |
| Tortora et al. | Management of gastrointestinal bleeding in rendu-osler disease | |
| ES2356158T3 (es) | Concentrados de proteínas plasmáticas terapéuticos que contienen factor von willebrand en calidad de multímeros de elevado peso molecular. | |
| Nilsson et al. | Surgery in von Willebrand's disease | |
| TOCANTINS | THE HEMORRHAGIC TENDENCY IN CONGESTIVE SPLENOMEGALY (BANTI'S SYNDROME): Its Mechanism and Management | |
| Laine et al. | Treatment of acute bleeding | |
| Qi et al. | Hemocoagulase might not control but worsen gastrointestinal bleeding in an elderly patient with type II respiratory failure | |
| JP6530564B2 (ja) | 抗凝固・抗血小板活性を有するマルチターゲット化合物及びその製法並びに用途 | |
| RU2618406C1 (ru) | Способ остановки гастродуоденального кровотечения | |
| Okten et al. | Use of Ankaferd Blood Stopper for controlling actively bleeding fundal varices | |
| Palmer | Haematemesis and melaena | |
| JPH11500709A (ja) | 副甲状腺機能亢進症処置のためのビタミンｋグループの使用 | |
| RU2657756C2 (ru) | Способ лечения кровотечений из верхних отделов желудочно-кишечного тракта | |
| Epperla et al. | 1174: METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS ENDOCARDITIS WITH B/L PAROTITIS AND ENDOPHTHALMITIS | |
| Erhard et al. | Before undertaking his craft, the artisan first sharpens his tools. | |
| Miranda et al. | S3086 Double-Balloon Enteroscopy in the Management of Overt Gastrointestinal Bleeding From a Rare Ileal Arteriovenous Malformation | |
| Abbad et al. | Diffuse Mesenteric and Bowel Angiodysplasia: A Case Report |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) | ||
| MM4Y | Short-term patent definitely lapsed due to non-payment of fees |